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Beneficial bacteria activate type-I interferon production via the intracellular
cytosolic sensors STING and MAVS
Jorge Gutierrez-Merino *, Beatriz Isla*, Theo Combes, Fernando Martinez-Estrada,
and Carlos Maluquer De Motes
School of Biosciences and Medicine, University of Surrey, GU2 7XH Guildford, UK
ABSTRACT
Type-I interferon (IFN-I) cytokines are produced by immune cells in response to microbial infections,
cancer and autoimmune diseases, and subsequently, trigger cytoprotective and antiviral responses
through the activation of IFN-I stimulated genes (ISGs). The ability of intestinal microbiota to
modulate innate immune responses is well known, but the mechanisms underlying such responses
remain elusive. Here we report that the intracellular sensors stimulator of IFN genes (STING) and
mitochondrial antiviral signaling (MAVS) are essential for the production of IFN-I in response to lactic
acid bacteria (LAB), common gut commensal bacteria with beneficial properties. Using human
macrophage cells we show that LAB strains that potently activate the inflammatory transcription
factor NF-κB are poor inducers of IFN-I and conversely, those triggering significant amounts of IFN-I
fail to activate NF-κB. This IFN-I response is also observed in human primary macrophages, which
modulate CD64 and CD40 upon challenge with IFN-I-inducing LAB. Mechanistically, IFN-I inducers
interact more intimately with phagocytes as compared to NF-κB-inducers, and fail to activate IFN-I in
the presence of phagocytosis inhibitors. These bacteria are then sensed intracellularly by the
cytoplasmic sensors STING and, to a lesser extent, MAVS. Accordingly, macrophages deficient for
STING showed dramatically reduced phosphorylation of TANK-binding kinase (TBK)-1 and IFN-I
activation, which resulted in lower expression of ISGs. Our findings demonstrate a major role for
intracellular sensing and STING in the production of IFN-I by beneficial bacteria and the existence of
bacteria-specific immune signatures, which can be exploited to promote cytoprotective responses
and prevent overreactive NF-κB-dependent inflammation in the gut.
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Introduction
Type-I IFN (IFN-I) such as IFN-α and IFN-β are poly-
peptides produced by innate immune cells in response to
infectious agents, particularly viral pathogens1. IFNs are
important to induce antimicrobial responses in an auto-
crine and paracrine manner via the synthesis of inter-
feron-stimulated genes (ISGs), and to modulate innate
immune responses that result in a balanced natural killer
cell response and effective antigenpresentation to activate
immunological memory through specific T and B cells
responses. IFN-I can also display protective roles against
bacterial infections, cancer and autoimmune diseases.2
Innate immune cells produce IFN-I upon recognition
of microbe-associated molecular patterns (MAMPs) via
pattern recognition receptors (PRRs). The first described
PRRs were Toll-like receptors (TLRs) and Nucleotide-
bindingoligomerizationdomain(NOD)-like intracellular
receptors (NLRs). These PRRs activate an intracellular
signaling cascade that converges on the pro-
inflammatory transcription factor nuclear factor kappa-
B (NF-κB), which is crucial in regulating anti-microbial
responses in the mucosa.3 The production of IFN-I
requires the additional and concomitant activation of
IFN regulatory factors (IRFs), which can be achieved via
the TLR adaptors myeloid differentiation primary
response 88 (MyD88) andTIRdomain-containing adap-
ter-inducing IFN (TRIF).4 More recently, the cytosolic
molecules stimulator of interferon genes (STING) and
mitochondrial antiviral signaling (MAVS) have been
identified as potent IFN-I inducers in response to nucleic
acids.5 STING is an endoplasmic reticulum-localized
transmembrane protein that becomes activated in the
presence of cytosolic DNA and the production of 2‘,3‘-
cyclic GMP-AMP (cGAMP) by the cGAMP synthase
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(cGAS).6–9 In addition, STING can also recognize other
cyclic dinucleotides (CDN) of prokaryotic origin.6,10
MAVS is a mitochondria-localized transmembrane pro-
tein that is activated by retinoic acid inducible gene
(RIG)-I andmelanoma differentiation-associated protein
(MDA)-5, two cytosolic sensors of 5‘ tri- and di-
phosphate RNA and stretches of dsRNA.11–13 Both
STING and MAVS coordinate the activation of TANK-
binding kinase (TBK)-1 and IRF3, which translocates
into the nucleus to initiate IFN production.14,15 The role
of STING and MAVS in inducing protective immune
responses in the presence of cytosolic DNA and RNA
such as those from viral infections or intracellular patho-
genic bacteria is well known,16,17 and in addition, STING
has recently been shown to mediate sensing and autop-
hagy of live gram-positive bacteria.18 However, the
impact of STING and intracellular sensing on immune
responses mediated by gut microbes remains relatively
unexplored.
Humans live in symbiosis with beneficial microbes
that inhabit different parts of the body, including the
gastrointestinal and respiratory tracts.19,20 Beneficial
microbes are composed of commensal bacteria that
are critical tomaintain homeostasis due to their invol-
vement in appropriate host immune responses. One
of the most significant bacterial groups associated
with host beneficial properties are lactic acid bacteria
(LAB),21 typical commensals that play an important
role in activating epithelial cells, antigen-presenting
cells and phagocytes.22 LAB interact with innate
immune cells via numerous MAMPs including pili
(fimbriae), peptidoglycans, lipo-teichoic acids, exopo-
lysaccharides and many other components of the cell
wall and membrane,22 that are recognized extracellu-
larly by TLR and NLR and trigger NF-κB
responses.21,22 A few studies have also reported that
LAB are capable of inducing protective pro-
inflammatory responses that depend not only on
NF-κB activation, but also on IRFs.23,24 The specific
mechanisms that LAB utilize to activate IRFs are
unknown, but it has been reported that the produc-
tion of type-I interferons (IFNs) requires the presence
of TLRs in endosomal compartments, including
TLR2 and TLR3.23,24
Here we demonstrate that different LAB spe-
cies induce specific immune responses in
human macrophages and primary cells, and
that those that activate IFN-I responses fail to
trigger NF-κB activation. Contrary to current
dogma in which beneficial bacteria are mostly
sensed by TLRs, we show that IFN-I-inducing
LAB are sensed intracellularly via cytosolic
nucleic acid sensors and that IFN-I production
and ISG induction is dependent on STING
and, to a lesser extent, MAVS. Our findings
provide a novel perspective into the interac-
tions between gut microbes and human cells
that have implications in the use of and manip-
ulation of beneficial commensal bacteria to
modulate human immune responses.
Results
LAB activate NF-κB or IFN-I responses in THP-1
macrophages
The ability of 12 LAB strains (Table 1) to
trigger the activation of the inflammatory tran-
scription factors NF-κB and IRF-3 was evalu-
ated in human differentiated THP-1 cells. We
employed 2 lines of THP-1 monocytes expres-
sing Gaussia luciferase (GLuc) under the con-
trol of either the NF-κB promoter or the
promoter of the IRF3-dependent gene IFN-
induced protein with tetratricopeptide repeats
(IFIT)-1. The cells were differentiated for 48
h and subsequently exposed to live or dead
LAB before GLuc activity was measured in
the media and presented as a fold increase
over non-stimulated macrophages (Figure 1
(a)). The majority of LAB species tested –
Streptococcus thermophilus, Pediococcus acidi-
lactici, Lactobacillus sakei, Lactobacillus kun-
keei, Lactobacillus casei, and Enterococcus
faecalis - induced significant NF-κB activation
and, with the exception of E. faecalis, this acti-
vation was enhanced in response to live bac-
teria compared to inactivated bacterial cells. By
contrast, we found that these isolates were poor
inducers of IFIT1 activation either dead or
alive. Interestingly, two bacterial species –
Pediococcus pentosaceus and Lactobacillus plan-
tarum – were able to induce a significant IFIT1
activation. This IFIT1 response was only
observed with viable bacteria and was espe-
cially high with L. plantarum. Interestingly,
neither P. pentosaceus nor L. plantarum
enhanced NF-κB activation when used as viable
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bacteria. To visualize this contrasting behavior,
we then plotted the recorded NF-κB vs IFIT1
activation for each LAB species and drew arbi-
trary cutoffs for NF-κB activation (~20 fold)
and IFIT1 (~10 fold) based on the most com-
mon response observed in all bacterial species
tested (Figure 1(b)). As expected most LAB
grouped in the top left quadrant (Q1) as
powerful NF-κB agonists, but poor IFIT1 indu-
cers. Strikingly, L. plantarum and
P. pentosaceus appeared in the bottom right
quadrant (Q4) as remarkably strong IFIT1
inducers, especially L. plantarum. The 2
L. lactis species occupied the bottom left quad-
rant (Q2) as intermediate NF-κB and IFIT1
inducers. We then performed dose-dependent
exposures with L. plantarum and P. pentosaceus
and showed that a challenge with 1
L. plantarum and 10 P. pentosaceus bacterial
cells per macrophage was sufficient to trigger
IFIT1 activation (Figure 1(c)). The highest
IFIT1 response was observed with a ratio of
25 bacteria per macrophage. Our screening
therefore indicated that some LAB could acti-
vate responses converging on IFN-I
production.
L. plantarum and P. pentosaceus activate
IFN-I production
To address expression of IFN-I and verify the
activation observed using luciferase reporters,
we used an IFN-stimulated responsive element
(ISRE)-based bioassay and a commercial ELISA
against the NF-κB-dependent inflammatory
cytokine TNF-α to quantify the presence of
TNF-α and IFN-I in the supernatants of
macrophages exposed to each of the LAB iso-
lates (Figure 2(a,b), respectively). Apart from
L. plantarum, P. pentosaceus and isolates of
L. lactis, the exposure of macrophages to all
LAB isolates resulted in high amounts of
TNF-α in the media, but very low levels of
IFN-I. Conversely, L. plantarum and
P. pentosaceus were capable of inducing
a significant ISRE activation as indicative of
effective production of IFN-I, especially in the
case of L. plantarum (Figure 2(b)). Similarly to
the luciferase-based results, when theTa
bl
e
1.
La
ct
ic
Ac
id
Ba
ct
er
ia
(L
AB
)
is
ol
at
es
us
ed
in
th
is
st
ud
y
Sp
ec
ie
s
St
ra
in
In
te
rn
al
co
de
So
ur
ce
Re
fe
re
nc
e
D
on
or
/C
ul
tu
re
co
lle
ct
io
n
En
te
ro
co
cc
us
fa
ec
al
is
N
CT
C
82
13
EF
H
um
an
ba
bi
es
’
fa
ec
es
25
Su
rr
ey
Cu
ltu
re
Co
lle
ct
io
n
La
ct
ob
ac
ill
us
ca
se
i
I-1
51
8
LC
Pr
ob
io
tic
D
rin
k
26
CN
CM
La
ct
ob
ac
ill
us
ku
nk
ee
i
O
29
LK
Be
e
po
lle
n
Th
is
st
ud
y
La
ct
ob
ac
ill
us
pl
an
ta
ru
m
W
CF
S-
1
LP
H
um
an
sa
liv
a
27
Pr
of
M
Kl
ee
re
be
ze
m
,W
ag
en
in
ge
n
U
ni
ve
rs
ity
,t
he
N
et
he
rla
nd
s
La
ct
ob
ac
ill
us
sa
ke
i
Lb
79
0
LS
1
M
ea
t
28
D
r
L
Ax
el
ss
on
,N
of
im
a
AS
,N
or
w
ay
La
ct
ob
ac
ill
us
sa
ke
i
L4
5
LS
2
N
or
w
eg
ia
n
fe
rm
en
te
d
dr
ie
d
sa
us
ag
e
29
Pr
of
IN
es
s,
N
or
w
eg
ia
n
U
ni
ve
rs
ity
of
Li
fe
Sc
ie
nc
es
La
ct
oc
oc
cu
s
la
ct
is
BB
S4
LL
1
Sp
an
is
h
fe
rm
en
te
d
dr
ie
d
sa
us
ag
e
30
Pr
of
PE
H
er
na
nd
ez
Cr
uz
a,
U
ni
ve
rs
id
ad
Co
m
pl
ut
en
se
de
M
ad
rid
La
ct
oc
oc
cu
s
la
ct
is
IO
-1
LL
2
Ki
tc
he
n
si
nk
w
at
er
31
Pr
of
H
Yo
sh
ik
aw
a,
To
ky
o
U
ni
ve
rs
ity
of
Ag
ric
ul
tu
re
Pe
di
oc
oc
cu
s
ac
id
ila
ct
ic
i
PA
C1
.0
PA
1
Fe
rm
en
te
d
fo
od
32
Pr
of
J
Ko
k,
G
ro
ni
ng
en
U
ni
ve
rs
ity
,t
he
N
et
he
rla
nd
s
Pe
di
oc
oc
cu
s
ac
id
ila
ct
ic
i
E1
PA
2
Ra
w
ho
ne
y
Th
is
st
ud
y
Pe
di
oc
oc
cu
s
pe
nt
os
ac
eu
s
N
CT
C
99
0
PP
D
rie
d
be
er
ye
as
t
33
Su
rr
ey
Cu
ltu
re
Co
lle
ct
io
n
St
re
pt
oc
oc
cu
s
th
er
m
op
hi
lu
s
I-1
61
3
ST
Yo
gu
rt
34
CN
CM
GUT MICROBES 3
production of TNF-α and IFN-I were plotted
we identified a strong IFN-I signature for
L. plantarum that correlated with a very low
impact on TNF-α (bottom right quadrant Q4
of Figure 2(c)). The arbitrary cutoffs for pro-
duction of TNF-α (~250 ng/mL) and IFN-I (~2
ISRE fold increase) were selected based on the
most common response observed in all LAB
tested. P. pentosaceus showed a more moderate
IFN-I signature and a slightly higher TNF-α
production than L. plantarum (next to the bot-
tom left quadrant Q2 of Figure 2(c)), but this
was still much lower than that observed with
most of the LAB isolates (top left quadrant Q1
of Figure 2(c)). Taken together, our screening
demonstrated that each LAB has the ability to
stimulate different innate immune responses in
human macrophages and that some are potent
inducers of IFN-I.
L. plantarum and P. pentosaceus activate
responses associated with IFN-I production in
human PBMCs
Next we sought confirmation of LAB-induced
IFN-I activation in human primary cells. We
first employed an IFN-β ELISA to detect and
Figure 1. Analysis of 12 LAB strains reveals that viable cells of Lactobacillus plantarum (LP) and Pediococcus pentosaceus (PP)
significantly induce IFIT1 activation in THP-1 macrophages in a dose-dependent manner. (a) Response of PMA-differentiated THP-1
macrophages to LAB isolates as a measurement of NF-κB (orange) and IFIT1 (red) activation. GLuc activation is presented as a fold
increase over a non-stimulated condition. LAB were used at a ratio of 1 macrophage per 100 inactivated bacterial cells (dark orange
and red) or 25 viable bacteria (light orange and red). LPS (gray bars) was used as a positive control in all screens. For each of the
isolates, a comparative statistical analysis was carried out between inactivated and viable cells using the Student’s t-test (**p < .01;
****p < .001). (b) Correlation between NF-κB and IFIT1 activation in PMA-differentiated THP-1 macrophages exposed to LAB at
a ratio of 1 macrophage per 25 viable bacteria. Activation is presented as a fold increase over a non-stimulated condition. Fold
increases of 20 and 10 were selected as arbitrary thresholds for NF-κB and IFIT1 activation, respectively, to divide the graph into
quadrants (Q1, Q2, Q3 and Q4). (c) IFIT1 activation in PMA-differentiated THP-1 macrophages challenged with viable cells of LP
(black bars) and PP (gray bars) at increasing macrophage:bacteria ratios of 1:1, 1:10, 1:25, 1:50 and 1:100. The activation is presented
as a fold increase over a non-stimulated condition.
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quantify the presence of this cytokine in the
supernatants of human monocyte-derived
macrophages collected from PBMC and
exposed to L. plantarum and P. pentosaceus
for 2 h. We observed a peak of IFN-β produc-
tion 8 h post-challenge that decreased at 12
h (Figure 3(a)). We then used flow cytometry
to monitor the expression of the IFN-I-related
markers CD64 and CD4035-37 in monocytes
collected from PBMC from two healthy donors
upon exposure to LAB. IFN-I expression has
been shown to down-regulate CD6437 and
upregulate CD40 in the presence of LAB.36 In
agreement with this, we observed that only
monocytes exposed to IFN-I-producing
L. plantarum and P. pentosaceus showed
a very significant reduction in CD64 expression
(Figure 3(b)) and an increase in CD40 expres-
sion (Figure 3(c)). No significant changes were
observed in the presence of L. casei, an isolate
Figure 2. Lactobacillus plantarum (LP) and Pediococcus pentosaceus (PP) barely induce TNF-α production in THP-1 macrophages but
significantly induce ISRE activation. (a-b) Supernatants obtained from THP-1 macrophages exposed to LAB isolates at a ratio of 1:25
were analysed for the presence of (a) TNF-α production using a commercial TNF-α ELISA and (b) ISRE activation using a pISRE-FLuc
/RLuc bioassay. In both cases, isolates on the right-hand side of the dotted line induced statistically significant responses compared
with the rest as determined by one way ANOVA followed by Fisher’s Least Significant Difference (LSD) Test (*p < .05; **p < .01; ****p
< .001). (c) Correlation between TNF-α production and ISRE activation in THP-1 macrophages exposed to each of the LAB selected in
this study at a ratio of 1:25. Doted lines indicate the thresholds used for TNF-α concentration (250 ng/mL) and ISRE activation (2-fold
increase) to divide the graph into quadrants (Q1, Q2, Q3 and Q4).
Figure 3. Lactobacillus plantarum (LP) and Pediococcus pentosaceus (PP) induce responses associated with IFN-I production in
monocytes and macrophages from PBMCs. (a) Production of IFN-β in supernatants obtained from primary macrophages after 0, 4, 8
and 12 h of being exposed to LP and PP. The INF-β levels were calculated using the Human IFN-β Quantikine ELISA Kit. Data are
representative of three healthy donors and are mean with SD from two biological replicates. (b-c) Expression of (b) CD64 and (c)
CD40 in monocytes (blue) and neutrophils (red) exposed to LP and PP as well as L. casei (LC) as a control (no IFN-I inducer). The CD
expression is presented as a percentage of fold change (increase or decrease) over a non-stimulated condition using unchallenged
monocytes and neutrophils. Data are mean with SD from two healthy donors and the comparative analysis was carried out with two-
way ANOVA and Tukey multiple comparison (*p < .05; **p < .01).
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that showed a potent NF-κB response but poor
IFN-I activation in our initial LAB screening.
These findings therefore confirmed that LAB
can trigger IFN-I responses in human primary
immune cells.
IFN-I-inducing LAB interact strongly with human
monocytes and macrophages
We next determined the mechanism by which some
LAB induce IFN-I production. First, we examined
whether L. plantarum and P. pentosaceus interact
with and/or are phagocytosed by human phagocytes
(monocytes and macrophages). We carried out three
independent assays using PBMCs,macrophages differ-
entiated from PBMCs and THP1 macrophages, at
a ratio of 1 phagocyte per 25 bacteria. This ratio ensures
a maximum activation of IFIT1 in phagocytes exposed
to either L. plantarum or P. pentosaceus (Figure 1(c)).
Firstly, we incubated FITC-labeled LAB with human
PBMC fromhealthy donors for 2 h and then processed
the samples by flow cytometry. We identified three
populations consisting of leukocytes, neutrophils and
monocytes (Figure 4(a), top panels) and then assessed
which of these had become positive for FITC (bottom
Figure 4. Human phagocytes from PBMCs interact with Lactobacillus plantarum (LP) and Pediococcus pentosaceus (PP). (a)
Interaction of LP and PP as well as L. casei (LC) as a control with monocytes and neutrophils from PBMCs of two healthy
donors. Viable bacterial cells were labeled with FITC and incubated in whole human blood for 1 h at a ratio of 1:25. Blood cell
populations were distinguished based on side scatter area (SSC-A) versus forward scatter area (FSC-A), and separated into
lymphocytes (gray), monocytes (blue) and neutrophils (red). Interaction with phagocytes was then observed in the FITC channel,
where the intensity was divided into three subpopulations based on the positivity: no interaction (-), binding and/or uptake (+),
and strong binding and/or uptake (++). (b-c) Percentage of (b) monocytes and (c) neutrophils in each of the three FITC
subpopulations [no interaction (-), binding and/or uptake (+), and strong binding and/or uptake (++)] after exposure to LC
(gray), LP (green) and PP (blue). The comparative analysis was carried out with two-way ANOVA and Tukey multiple comparisons
(*p < .05; **p < .01; ***p < .005; ****p < .001). (d) Confocal microscopy images showing the detection of LP and PP at the
vicinity and/or inside monocyte-derived macrophages (indicated with arrows). FITC and DAPI were used to label bacteria and the
macrophage nucleus, respectively.
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Figure 5. Human THP-1 macrophages interact with Lactobacillus plantarum (LP) and Pediococcus pentosaceus (PP). (a) Number of
L. casei (LC), LP or PP cells that were internalized and/or attached to THP1 macrophages after a 2 h RPMI incubation in the absence
(white) or presence (black) of the phagocytosis inhibitor cytochalasin D. The bacterial intake and/or attachment was calculated as the
difference between the number of bacteria found in the supernatant of THP-1 cells at 0 and 2 h post-LAB challenge, and presented as
number of bacteria per macrophage (Mφ). Comparative analysis was carried out using the Student t-test (ns, no significant; ***p < .005;
****p < .001). (b) IFIT1 activation in PMA-differentiated IFIT1-GLuc THP-1 macrophages exposed to LC, LP or PP in the absence (white) or
presence (black) of cytochalasin D. The activation of IFIT1 is presented as a fold increase over a non-stimulated condition. The bacterial
challenge was carried out at a ratio of 1 macrophage per 25 bacteria (**p < .01; ****p < .001; Student’s t-test). (c) Decrease in bacterial
counts for LC, LP and PP after a 2 h RPMI incubation in the absence (white) or presence (black) of cytochalasin D. The bacterial decrease
was calculated as the difference between the number of viable bacteria after 2 h of incubation and expressed as log10CFU/mL (ns, no
significant; ***p < .005, ****p < .001; Student’s t-test).
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panels). This assay showed that monocytes and neu-
trophils (blue and red populations) shifted significantly
in the presence of L. plantarum and P. pentosaceus, but
not with the NF-κB inducer L. casei. We quantitated
these data and observed that contrary to L. casei, both
L. plantarum andP. pentosaceus interacted significantly
withmonocytes (Figure 4(b)) andneutrophils (Figure 4
(c)). Secondly, we differentiated PBMCmonocytes into
macrophages and observed them by confocal micro-
scopy upon incubation with FITC-labeled
L. plantarum and P. pentosaceus. We were able to
visualize FITC+ cells (Figure 4(d)), indicating that
a strong interaction occurred between LAB and pri-
mary human macrophages. Finally, we studied the
effect of pharmacological inhibition of phagocytosis
on the internalization of L. plantarum and
P. pentosaceus in human THP-1 macrophages (Figure
5). We observed that the number of L. plantarum and
P. pentosaceus that remain inside (and/or attached to)
THP1 macrophages was significantly lower in the pre-
sence of the phagocytosis inhibitor cytochalasin
D following a 2 h incubation in RPMI (Figure 5(a)).
Concomitant with this decrease, the activation of the
IFIT1-GLuc reporter upon exposure to L. plantarum
and P. pentosaceus was significantly reduced in the
presence of cytochalasin D (Figure 5(b)). Cytochalasin
D did not affect bacterial viability (Figure 5(c)) nor
affected reporter activation by unrelated agonists such
as LPS (not shown). Taken together, these results
strongly suggest that L. plantarum and P. pentosaceus
interact and/or are internalized by human
macrophages.
STING and MAVS sense L. plantarum and
P. pentosaceus to activate the IFN-I associated
kinase TBK1
STING and MAVS are potent IFN-I inducers that
respond to cytosolic MAMPs. Having observed that
IFN-I-inducing LAB were internalized by macro-
phages, we explored whether these cytosolic sensors
could account for the observed immune responses.
We then used THP-1-IFIT1-GLuc cells deficient for
STING (STING KO) or MAVS (MAVS KO).38 We
Figure 6. STING and MAVS sense Lactobacillus plantarum (LP) and Pediococcus pentosaceus (PP), resulting in the activation of the
IFN-I associated kinase TBK-1. (a, c) IFIT1-GLuc activation in PMA-differentiated control (gray), STING knock-out (blue) and MAVS
knock-out (red) THP-1 cells in response to (a) LP or (c) PP. IFIT1 activation is presented as a fold increase over a non-stimulated
condition after 12 and 24 h of incubation using a ratio of 1 macrophage per 25 viable bacteria. For each time point, a comparative
statistical analysis was carried out between the control and the knock-out cells using the Student’s t-test (*p < .05; **p < .01; ***p <
.005). (b-d) Immunoblotting against the indicated proteins in whole-cell lysates from PMA-differentiated control, STING and MAVS
knock-out THP-1 cells exposed to (b) LP or (d) PP at the indicated doses.
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differentiated these cells into macrophages and chal-
lenged them with viable cells of L. plantarum and
P. pentosaceus before measuring GLuc activity. As
expected, control cells responded strongly to
L. plantarum and IFIT1 activation reached 10 and
40 fold increase at 12 and 24 h after challenge.
However, this response was completely abrogated
in STING KO cells (Figure 6(a)). The response in
MAVS KO cells was also reduced, but this was less
evident, being only statistically significant after 24
h of bacterial challenge. To verify the role of STING
in L. plantarum-induced IFIT-1 activation, we exam-
ined the levels of phosphorylated TBK-1 in the
lysates of cells exposed to different L. plantarum
doses. Phosphorylated TBK-1 was absent in mock-
challenged cells, but was readily detected 2 h after
bacterial challenge in a dose-dependent manner
(Figure 6(b)). In the absence of STING, we barely
detected any phosphorylated TBK-1, whilst in the
absence of MAVS, a reduction was appreciated in
agreement with the reporter data. We then assessed
the response to P. pentosaceus. As shown previously,
exposure to P. pentosaceus triggered a lower
response than that to L. plantarum and control
cells showed elevated luciferase activity at 24 h post-
challenge (Figure 6(c)). However, this was also dras-
tically reduced in STING KO cells and partially
reduced in the absence of MAVS (Figure 6(c)).
Accordingly, levels of phosphorylated TBK1 were
also diminished in the absence of STING or MAVS
(Figure 6(d)). Collectively, our results demonstrate
that L. plantarum and P. pentosaceus are sensed by
Figure 7. The IFN-I response of macrophages to Lactobacillus plantarum (LP) and Pediococcus pentosaceus (PP) is dependent on
STING and MAVS. (a, b) Level of relative mRNA expression of IFN-β, MxA and OAS1 in IFIT1-GLuc THP-1 macrophages (control, gray)
and their corresponding knockouts (KO) for STING (red) and MAVS (blue) after exposure to (a) LP or (b) PP for 8 h at a ratio of 1
macrophage per 25 viable bacteria. The relative expression of each gene is presented as a fold induction following normalization
with the internal control gene TBP and nonstimulated THP-1 macrophages. A comparative statistical analysis was carried out
between the control and the knockout cells using the Student’s t-test (*p < .05, ***p < .005). (C, D) ISRE activation from supernatants
obtained from IFIT1-GLuc THP-1 macrophages (control, gray) and their corresponding knockouts (KO) for STING (red) and MAVS
(blue) after exposure to (c) LP or (PP) for 24 h at a ratio of 1 macrophage per 25 viable bacteria. The ISRE activation for each cell line
was calculated as a fold increase using a pISRE-FLuc/RLuc reporter cell line after 10 h of supernatant exposure and then indicated as
a percentage relative to control. A comparative statistical analysis was carried out between the control and the knockout cells using
the Student’s t-test (**p < .01; ***p < .005).
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mechanisms that involve the intracellular sensors
STING and, to a lesser extent, MAVS.
STING and MAVS are required to induce IFN-I in
response to LAB
To evaluate the influence of STING and MAVS on
the ability of L. plantarum and P. pentosaceus to
activate IFN-I responses, we determined the
induction of IFN-I and IFN-I-associated genes
from STING and MAVS KO macrophages
exposed to L. plantarum and P. pentosaceus at
a ratio of 25 bacteria per macrophage (Figure 7).
We first measured the relative expression of IFN-β,
MxA and OAS1 in the challenged KO macro-
phages (Figure 7(a,b)). After 8 h of bacterial chal-
lenge with L. plantarum we detected a significant
increase in the mRNA expression of IFN-β in the
control cells (Figure 7(a)). In both STING and
MAVS KO cells, this increase was significantly
lower, in particular in the STING KO cells.
Similarly, the absence of STING and MAVS in
cells previously exposed to L. plantarum resulted
in a significant decrease in the expression levels of
MxA and OAS1, two well-known ISGs. The
mRNA expression of these two ISGs, as well as
IFN-β, also decreased in STING KO and MAVS
KO cells challenged with P. pentosaceus as com-
pared with the control cells (Figure 7(b)).
However, only the reduction in IFN-β expression
was found to be statistically significant. Finally,
media from cells exposed to L. plantarum (the
most potent inducer of IFN-I) were subjected to
ISRE bioassay. In agreement with gene expression
data, absence of STING and, to a lesser extent
MAVS, significantly reduced the amount of biolo-
gically active IFN-I (Figure 7(c)). We observed
similar results with KO cells exposed to
P. pentosaceus but the reduction in functional
IFN-I was less clear and equally significant from
both KO cells (Figure 7(d)).
Discussion
Human cells express multiple PRRs aimed at
detecting the presence of foreign molecules includ-
ing those from bacteria and viruses. Such recogni-
tion activates signaling mechanisms that converge
in the production of cytokines and chemokines.
Currently, the central dogma is that commensal
species are sensed by TLRs and NLRs and trigger
activation of NF-κB. Certainly, LAB, a major com-
mensal group, have been shown to activate NF-κB
via TLR2,39 TLR940 and NLRs.41 A few studies
have also shown that LAB are capable of inducing
the production of IFN-I in innate immune
cells,23,24,42,43 and when the mechanism has been
reported, this has been linked with TLR2/3 recog-
nition via endosomes.23,24 In this study, we report
the production of IFN-I by LAB in human macro-
phages and demonstrate that such production is
mediated by intracellular sensing driven by the
nucleic acid sensors STING and MAVS. Our find-
ings were generated from an initial-unbiased
screen using different representative LAB species.
This screen showed that macrophage challenge
with LAB species such as E. faecalis, L. casei,
L. sakei and P. acidilactici resulted in very high
NF-κB activation, as widely reported in previous
publications.44–47 However, unlike most of the
selected LAB, L. plantarum and P. pentosaceus
failed to significantly activate the NF-κB pathway,
but were instead able to induce production of IFN-
I in human macrophage-like cells and human pri-
mary phagocytes isolated from PBMCs. LAB
induction of IFN-I production was species-
specific since it was not observed for other lacto-
bacilli and pediococci tested in our screen. This
bacterial specificity has been confirmed with other
strains of L. plantarum and P. pediococcus that we
have recently isolated from animals.47,48 The level
of IFN-I produced by these bacteria in macro-
phages was detectable by ELISA, but more impor-
tantly, it induced upregulation of CD40 and
downregulation of CD64, both of which are well-
known IFN-I-responsive markers.35–37 In this
respect, Weiss et al. found that LAB that induce
IFN-β activation are also able to stimulate CD40 in
murine bone marrow derived dendritic cells,36
a positive convergence that we have confirmed
here using human primary monocyte-derived
macrophages. Furthermore, IFN-I triggered the
production of ISGs in the form of MxA and
OAS1, effectively activating an antiviral response.
Our work therefore may provide explanations for
how the composition of microbial communities
and specific bacterial groups modulate innate
immune responses during virus infection,49 an
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emerging field with impact on gastrointestinal and
non-gastrointestinal infection as well as vaccines.
The IFN-I activation that we have recorded here
required live bacteria and their interaction with
paghocytes, as previously reported with dentritic
cells stimulated with other LAB species.23 Alive
cells of L. plantarum and P. penstosaceus triggered
an endogenous IFN-I production that was signifi-
cantly higher than that observed with inactivated
cells. In general, macrophages exposed to heat-
killed (or inactivated) bacterial cells activate TRL/
NOD-like receptors-dependent pathways, whereas
live bacteria activate other pathways that require
phagocytosis and bacterial degradation in the pha-
golysosome, which may lead to the release of bac-
terial intracellular components into the cytosol.50
Recently, it has been shown that STING is essen-
tial to activate an integrated stress response to live
Gram-positive bacteria particularly Listeria, and
that part of this response involves the late produc-
tion of IFN-I.18 STING activation occurred upon
engagement with the CDN c-di-AMP secreted by
these bacteria and therefore it bypassed
cGAS.18,51,52 Whilst many clinically relevant
Gram-positive bacteria including L. monocytogenes
or Mycobacterium tuberculosis produce c-di-AMP
and are hence susceptible to STING responses, it is
unclear whether this is also the case for LAB. The
synthesis of CDNs has been described in LAB, but
very little is known about their role in bacterial
physiology and host innate immune responses.53
More recent work has identified the oxidoreduc-
tase RECON as a high-affinity cytosolic sensor of
CDNs including c-di-AMP,54 and it has been pro-
posed that bacteria such as L. monocytogenes
secrete c-di-AMP to inhibit RECON and relieve
RECON-mediated NF-κB inhibition to promote
bacterial spread.55 Therefore, if LAB were inducing
IFN-I via c-di-AMP secretion, a concomitant
increase in NF-κB response would have been
expected. Our findings indicating that IFN-
I-inducing LAB hardly activated NF-κB suggest
that other PAMPs and mechanisms may be
responsible for STING sensing. A possible expla-
nation to account for the observed STING-
dependent responses would be the release of bac-
terial DNA into the cytosolic millieu acting as an
intracellular PAMP. We believe that the
requirement for live LAB cells could be associated
to the process of internalization and subsequent
DNA recognition by professional phagocytes.
Recent studies have reported that the cytosolic
sensors STING and MAVS are important to main-
tain gut homeostasis and prevent autoimmune con-
ditions such as inflammatory bowel disease
(IBD).56,57 Our results are in line with these latest
discoveries. Although multiple commensals might
be involved in beneficial nucleic acid responses in
the gut, our study has identified L. plantarum as
a potential key player. We have proved that
L. plantarum interacts intimately with human pha-
gocytes and that this close interaction is essential to
activate IFN-I responses via STING and MAVS. We
have also observed that L. plantarum failed to acti-
vate NF-κB, a transcription factor that drives
pathology in many inflammatory disorders. In
these, microbial dysbiosis and the continuous pro-
duction of potent NF-κB-mediated inflammatory
cytokines such as TNF-α drive perpetual inflamma-
tion. IFN-I is emerging as an important cytoprotec-
tive signature in mucosal tissues including the
gut.58,59 Therefore, L. plantarum and their mechan-
isms could assist in targeting the underlying
microbe-immune cell interactions and inducing
beneficial anti-inflammatory cytokines. L. plan-
tarum is a frequent inhabitant of mucosal tissues
where a variety of immune cells including macro-
phages and dendritic cells lie and it is widely recog-
nized as a potential immunomodulator. At present,
it is unclear how L. plantarum is recognized by
macrophage receptors and what properties this bac-
terium has to account for its ability to activate
STING and MAVS. Our results comparing phago-
cytic uptake of L. plantarum with other LAB such as
L. casei (Figure 4) indicates that the level of inter-
action with human phagocytes might be
a prominent differential feature, which eventually
leads to phagocytic uptake and intracellular proces-
sing of the bacterial cells. Although multiple factors
may exist, one possibility explaining this enhanced
interacting capacity is the ability of L. plantarum to
express adhesins that facilitate interactions with
other cells.60 The oral administration of
L. plantarum as a probiotic is common and remark-
ably it has resulted in a significant reduction in
respiratory tract infections in newborns.61 These
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probiotic features and the mechanisms underlying
the IFN-I activation that we report in this work
indicate that L. plantarum might be an excellent
candidate to mitigate inflammation as well as
enhancing protective antiviral responses.
In summary, our findings highlight the value of
LAB and their molecules as potential mediators of
host protective IFN-I responses via the cytosolic
sensors STING and MAVS. A better understanding
of the STING-mediated IFN-I regulation by
L. plantarum and other LAB that have a very low
impact on NF-κB-mediated pro-inflammatory cyto-
kines could be helpful in the design of future pro-
biotic therapies addressing human gut disorders.
Materials and methods
Ethics statement
All procedures with human blood samples have
been approved by the Surrey University Ethics
Committee in accordance with the Institutional
Policy on the Donation and Use of Human
Specimens in Teaching and Research and the
national guidelines under which the institution
operates. The blood protocol approval was under
IRAS number 236477 and the sample storage was
carried out under HTA license 12365.
Human peripheral blood mononuclear cells
(PBMC) and macrophages
Whole fresh blood was collected in heparinized
tubes from healthy individuals to carry out the
phagocytosis assay. To generate macrophages,
monocytes were first isolated from buffy coats of
the healthy blood donors by Lymphoprep (Axis-
Shield) density gradient centrifugation followed by
plastic adherence in Roswell Park Memorial
Institute (RPMI) 1640 (Life Technologies) supple-
mented with 15% fetal bovine serum (FCS,
Seralab) and 1% Penicillin/Streptomycin (Pen/
Strep, Life Technologies) at 37°C in an atmosphere
of 5% CO2. The collected peripheral blood mono-
nuclear cells (PBMCs) were incubated for 2 h to
remove nonadherent cells by washing with PBS.
The adherent monocytes were then detached using
10 mM EDTA in PBS at room temperature and
plated for macrophage maturation in RPMI with
FCS and Pen/Strep for 7 days.
THP-1 cell lines and macrophage differentiation
THP-1 cells were propagated in RPMI supplemen-
ted with 15% FCS and 1% Pen/Strep. THP-
1-κB-GLuc (Lucia™ NF-κB) express and secrete
Gaussia luciferase (GLuc) under the control of
a synthetic 5x-κB promoter (Invivogen). THP-
1-IFIT1-GLuc express and secrete Gluc under the
control of the promoter of the IRF-3-dependent
gene IFIT1 and were a gift from Veit Hornung.62
THP-1-IFIT1 deficient for STING or MAVS, and
its corresponding control, were kindly provided by
Greg Towers and have been previously
described.38 THP-1 monocytes were differentiated
into macrophages in RPMI supplemented with 20
ng/mL of phorbol 12-myristate 13-acetate (PMA)
for 48 h as previously described.63 After the 48
h incubation medium was replaced for RPMI con-
taining 2% FCS and 1% Pen/Strep and macro-
phages exposed to LAB. PMA was from Santa
Cruz Biotechnology and kept in DMSO at
10 mg/mL.
Growth and maintenance of LAB
The LAB selected for this study is shown in Table
1 and are reference strains with accessible peer-
reviewed publications and/or genome sequences
with the exception of Pedioccocus acidilactici (iso-
late E1) and Lactobacillus kunkeei (isolate O29).
The genomes of the newly-characterized isolates
E1 and O29 and their corresponding sequencing
reads, assemblies and metadata have been
uploaded onto Genbank in BioProject
PRJNA544274. All the isolates were grown in
MRS broth (Oxoid) at 37ºC without any aeration
for 24 h, and maintained as −80°C frozen stocks in
their appropriate media with the addition of 15%
glycerol.
Bacterial challenge
PMA-differentiated THP-1-NF-κB-GLuc and
THP-1-IFIT1-GLuc macrophages were exposed
to inactivated and viable LAB cells. The inactivated
cells were used as heat-treated (70°C, 2 h) LAB
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pellets at a ratio of 100 cells per 1 macrophage and
incubated for 24 h, while viable cells were incu-
bated simultaneously with the macrophages for 2
h in RPMI without Pen/Strep at different doses as
indicated in the figure legends before being
replaced for fresh RPMI with antibiotics to incu-
bate for a further 22 h. To measure Gluc activity,
media were collected from the macrophage cul-
tures and transferred to white-bottom 96-well
plates, which were read in a Clariostar plate reader
(BMG Biotech) in the presence of 2 μg/mL of
coelenterazine (NanoLight Technology). LPS
(Sigma Aldrich) was used at 0.2 mg/ml as
a control for the activation of NF-κB and IFIT1.
Activation of NF-κB or IFIT1 was calculated as
a fold increase ± SD over the measurements
recorded for unchallenged macrophages.
Bacterial interaction with THP-1 macrophages
In order to estimate the number of LAB that interact
with and/or are internalized by THP-1 macrophages,
we carried out an extracellular survival assay as pre-
viously described64 with minor modifications.
Macrophages were incubated with viable LAB at
a ratio of 25 bacteria per phagocyte in RPMI contain-
ing 2% FCS for 2 h, at 37°C and 5% CO2.
Macrophages were treated with the phagocytosis
inhibitor cytochalasin D at a final concentration of
10 μM (Sigma-Aldrich) and subsequently challenged
with LAB. LAB were also incubated without macro-
phages under the same experimental conditions (with
or without cytochalasin D). Supernatants were then
collected at time points 0 and 2 h to calculate and
compare the number of bacteria that remained viable
and detached from THP-1 macrophages. Bacterial
enumeration was performed by quantitative plating
of serial dilutions on MRS agar plates.
Phagocyte assay with human peripheral blood
mononuclear cells (PBMC)
Approximately 106 leukocytes were mixed 1:1 with
10 mM EDTA in PBS and challenged with LAB
that were previously labeled with the FITC dye
(Sigma), at a ratio of 25 bacteria per cell. The
phagocytosis incubation was then carried out at
37°C in an orbital shaker for 1 h and subsequently
treated with 1x RBC lysis solution (Biolegend)
following incubation at room temperature for 15
min. The cells were washed twice with 10nM
EDTA in PBS, resuspended in PBS and analyzed
on FACS Celesta instrument (BD Biosciences).
Flow cytometry analysis based on forward (FSC)
and side (SSC) scatter was used to distinguish the
main blood cell populations based on their size
and granularity (lymphocytes vs. phagocytes),
while the FITC channel was used to measure bac-
terial interaction with blood cells. The resulting
SCC/FITC plots were then used to quantify the
LAB intake by phagocytes.
CD expression in phagocytes from human PBMCs
In order tomonitor the expression of CD40 and CD64
in monocytes and neutrophils exposed to LAB we
carried out the phagocytosis assay as described above
but with some modifications. Leukocytes and bacteria
were mixed at 1:100 ratios and incubated for 1 h. After
phagocytosis incubation antibodies against human
CD40-BV510 and CD64-PE/Dazzle (Biolegend), or
the corresponding isotype controls, were added to the
samples and incubated for 20 min at room tempera-
ture. The fixable viability dye Zombie NIR (Biolegend)
was also used for a live/dead stain as per manufac-
turer’s instructions. Cells were then fixed with RBC
lysis buffer and the CD expression compared to the
matching isotype control and no-bacteria controls to
calculate expression levels in each of the blood cells
populations identified by FACS.
Microscopy studies on monocyte-derived
macrophages from human PBMCs
Monocyte-derived macrophages were challenged for 2
hwithFITC-labeledLABas described above forTHP-1
cells. After phagocytosismacrophages were fixed for 20
min with 1% paraformaldehyde (PFA), washed with
PBS without Calcium or Magnesium and stained with
DAPI for imaging on an EVOS fluorescent
microscopy.
SDS-PAGE and immunoblotting
LAB-challenged THP-1 cells were lysed in radio-
immuno-precipitation assay (RIPA) buffer supple-
mented with protease and phosphatase inhibitors
(Roche) and benzonase at 250 U/ml (Sigma).
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Lysates were rotated for 30 min at 4°C and subse-
quently denatured for 5 min at 95°C in the presence
of loading buffer and resolved by SDS-PAGE. The
samples were then transferred to nitrocellulose
membranes (GE Healthcare) using a Trans-Blot
semidry transfer unit (Bio-Rad). Membranes were
blocked in 0.1% Tween/phosphate-buffered saline
supplemented with 5%-skimmed milk (Sigma) and
subjected to immunoblotting with the following pri-
mary antibodies at the indicated dilutions: phos-
phorylated TBK-1 Ser17 (Abcam; 1:5,000), TBK−1
(Abcam; 1:5,000) and α-tubulin (Upstate Biotech;
1:10,000). Primary antibodies were detected using
IRDye-conjugated secondary antibodies in an
Odyssey infrared imager (LI-COR Biosciences).
Images were analyzed using Odyssey software.
Quantitative RT-PCR
PMA-differentiated THP−1 cells were exposed to
LAB for 8 h and cells were collected for RNA
extraction using the High Pure RNA Isolation
Kit (Roche Diagnostics Limited) following man-
ufacturer’s instructions. RNA was reverse tran-
scribed using the SuperScript ® III First-Strand
Synthesis System from Invitrogen and the result-
ing cDNA diluted 1:5 in water. cDNA was then
used as a template for real-time amplification on
a QuantStudio 7 Flex Real-Time PCR system
(Applied Biosystems) using SYBR Green Master
Mix (Applied Biosystems) and specific primers
for: TATA box Binding Protein (TBP) (forward,
5ʹTGCACAGGAGCCAAGAGTGAA; reverse, 5ʹ
CACATCACAGCTCCCCACCA), myxovirus
resistance gene A (MxA) (forward, 5ʹ
CCCCAGTAATGTGGACATCG; reverse, 5ʹ
ACCTTGTCTTCAGTTCCTTTGT), human 2ʹ5’-
oligoadenylate synthetase 1 (OAS1) (forward, 5ʹ
TGTGTGTGTCCAAGGTGGTA; reverse, 5ʹ
TGATCCTGAAAAGTGGTGAGAG), and
human IFNβ (described previously65) using
three technical replicates of samples obtained
from three biological replicates. Expression of
each gene was normalized to the house-keeping
gene TBP, and these values were then normal-
ized to the non-stimulated control cells to yield
a fold induction.
ISRE-based IFN-I bioassay
Cell culture supernatants from LAB–challenged,
PMA-differentiated THP-1 macrophages were col-
lected after 24 h of incubation and transferred to 96-
well plates containing HEK293T cells previously
transfected for 24 h with 70 ng/well of a reporter
plasmid expressing firefly luciferase (FLuc) under
the control of ISRE and 10 ng/well of a control
plasmid expressing Renilla luciferase (RLuc)
(Promega) using polyethylenimine (PEI; Sigma) at
a ratio of 1:2 (μg of DNA:μl of PEI). After 10 h the
cells were lysed in passive lysis buffer (Promega) and
the FLuc and RLuc activities measured in the
Clariostar plate reader (BMG Biotech). The FLuc/
RLuc ratios were then calculated for each well and
normalized to mock-infected THP-1 samples to be
presented as a fold increase of ISRE activation.
ELISA cytokine detection
Human TNF-α production was detected and
quantified in the supernatants of LAB-challenged
PMA-differentiated THP-1 cells using the
eBioscience Human TNF-α ELISA Ready-SET-Go
kit as indicated by the manufacturer’s instructions.
The Human IFN-β Quantikine ELISA Kit (R&D
systems) was used to detect and quantify IFN-β in
supernatants from primary macrophages exposed
to LAB for 2 h. Supernatants were collected every
4 h for 12 h after the exposure to LAB.
Statistical analysis
Statistical analysis was performed using GraphPad
Prism. Data are presented as means ± standard
deviation (SD) and are representative of one
experiment of at least three independent experi-
ments. Data from experiments with human per-
ipheral blood mononuclear cells are representative
of two or three healthy donors and are mean with
SD from two biological replicates. Statistical sig-
nificance between one sample and its correspond-
ing control was determined using the Student’s
t-test and within a group of samples using one
way ANOVA followed by Fisher’s Least
Significant Difference (LSD) Test.
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